~~<i id='501221B026'><strike id='501221B026'><tt id='501221B026'><pre id='501221B026'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：entertainment 2025-08-23 18:37:58 - browse：46

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Wegovy cuts risk of cardiovascular events by 20%, study finds

knowledge

hotspot

leisure time

knowledge

Wikipedia

ArtemisIIcrewmembers,fromleft,JeremyHansen,VictorGlover,ReidWisemanandChristinaKoch,standtogetheratN

WSS

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Biden praises World Series champion Astros for impact off the field during White House celebration

The future of health care in the House

What to expect at HLTH 2023, the health care industry conference

Sana to lay off nearly a third of staff, de

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

explore

hotspot

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

What to expect at HLTH 2023, the health care industry conference

Drug repurposing or repositioning? The language matters

Physician executives need more than on

Hollywood unions extend contract negotiations for actors

FTX founder Sam Bankman

Trump demands the U.S. pay no more for drugs than other countries … again

Analysis of telehealth claims data suggest service duplication

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Judge rejects Trump's counterclaim against E. Jean Carroll

hotspot

Analysis of telehealth claims data suggest service duplication

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Hospitals use virtual reality to design more inclusive rooms for kids

leisure time

knowledge

knowledge

Wikipedia